1. Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patients. (May 2015) Authors: Myler, Heather; Hruska, Matthew W; Srinivasan, Subasree; Cooney, Elizabeth; Kong, George; Dodge, Robert; Krishna, Murli; Zhu, Jie; Felix, Tonya; Gleason, Carol; Piccoli, Steven P; DeSilva, Binodh Journal: Bioanalysis Issue: Volume 7:Number 9(2015) Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022) Authors: Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu... Journal: Lancet neurology Issue: Volume 21:Issue 7(2022) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extended-interval dosing of natalizumab in NOVA – Authors' reply. Issue 3 (March 2023) Authors: Foley, John F; Campbell, Nolan; Kong, George Journal: Lancet neurology Issue: Volume 22:Issue 3(2023) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial. Issue 7 (July 2016) Authors: Weber, Jeffrey S; Gibney, Geoff; Sullivan, Ryan J; Sosman, Jeffrey A; Slingluff, Craig L; Lawrence, Donald P; Logan, Theodore F; Schuchter, Lynn M; Nair, Suresh; Fecher, Leslie; Buchbinder, Elizabeth I; Berghorn, Elmer; Ruisi, Mary; Kong, George; Jiang, Joel; Horak, Christine; Hodi, F Stephen Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗